Toxoplasma gondii ROP5 Enhances Type I IFN Responses by Promoting Ubiquitination of STING

被引:0
|
作者
Jin, Qi-Wang [1 ,2 ]
Yu, Ting [1 ]
Pan, Ming [1 ]
Fan, Yi-Min [1 ]
Ge, Ceng-Ceng [1 ]
He, Xiao-Bing [2 ]
Gong, Jing-Zhi [1 ]
Tao, Jian-Ping [1 ]
Fu, Bao-Quan [2 ]
Jing, Zhi-Zhong [2 ]
Huang, Si-Yang [1 ]
机构
[1] Yangzhou Univ, Inst Comparat Med, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Peoples R China
[2] Lanzhou Univ, Lanzhou Vet Res Inst, State Key Lab Anim Dis Control & Prevent, Chinese Acad Agr Sci,Coll Vet Med, Lanzhou 730000, Peoples R China
基金
中国博士后科学基金;
关键词
<italic>Toxoplasma gondii</italic>; ROP5; cGAS-STING pathway; ubiquitination; CYCLIC GMP-AMP; KAPPA-B ACTIVATION; PSEUDOKINASE ROP5; GENE-EXPRESSION; CELL RESPONSES; IL-6; CONTROLS; IMMUNE; VIRULENCE; FAMILY; 2ND-MESSENGER;
D O I
10.3390/ijms252011262
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toxoplasma gondii is a widely spread opportunistic pathogen that can infect nearly all warm-blooded vertebrates and cause serious toxoplasmosis in immunosuppressed animals and patients. However, the relationship between the host's innate immune system and effector proteins is poorly understood, particularly with regard to how effectors antagonize cGAS-STING signaling during T. gondii infection. In this study, the ROP5 from the PRU strain of T. gondii was found to promote cGAS-STING-mediated immune responses. Mechanistically, ROP5 interacted with STING through predicted domain 2 and modulated cGAS-STING signaling in a predicted domain 3-dependent manner. Additionally, ROP5 strengthened cGAS-STING signaling by enhancing the K63-linked ubiquitination of STING. Consistently, ROP5 deficient PRU (PRU Delta ROP5) induced fewer type I IFN-related immune responses and replicated faster than the parental strain in RAW264.7 cells. Taken together, this study provides new insights into the mechanism by which ROP5 regulates T. gondii infection and provides new clues for strategies to prevent and control toxoplasmosis.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] TYPE I IFN SIGNALING IN CANCER CELLS ENHANCES CHEMOTHERAPY RESPONSES
    不详
    CANCER DISCOVERY, 2014, 4 (12) : 1365 - 1365
  • [22] Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
    Larkin, Bridget
    Ilyukha, Vladimir
    Sorokin, Maxim
    Buzdin, Anton
    Vannier, Edouard
    Poltorak, Alexander
    JOURNAL OF IMMUNOLOGY, 2017, 199 (02): : 397 - 402
  • [23] Borrelia burgdorferi Engages Mammalian Type I IFN Responses via the cGAS-STING Pathway
    Farris, Lauren C.
    Torres-Odio, Sylvia
    Adams, L. Garry
    West, A. Phillip
    Hyde, Jenny A.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (11): : 1761 - 1770
  • [24] Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING
    Rueckert, Christine
    Rand, Ulfert
    Roy, Urmi
    Kasmapour, Bahram
    Strowig, Till
    Guzman, Carlos A.
    FASEB JOURNAL, 2017, 31 (07): : 3107 - 3115
  • [25] Type II Toxoplasma gondii Induction of CD40 on Infected Macrophages Enhances Interleukin-12 Responses
    Morgado, Pedro
    Sudarshana, Dattanand M.
    Gov, Lanny
    Harker, Katherine S.
    Lam, Tonika
    Casali, Paolo
    Boyle, Jon P.
    Lodoen, Melissa B.
    INFECTION AND IMMUNITY, 2014, 82 (10) : 4047 - 4055
  • [26] Leptospira spp. are a potent activator of Type I IFN responses via the cGAS-STING pathway
    Gupta, Suman
    Matsunaga, James
    Cassel, Suzanne L.
    Haake, David A.
    Sutterwala, Fayyaz S.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [27] Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides
    Yu, Zizi
    Vieyra-Garcia, Pablo
    Benezeder, Theresa
    Crouch, Jack D.
    Kim, Ira R.
    O'Malley, John T.
    Devlin, Phillip M.
    Gehad, Ahmed
    Zhan, Qian
    Gudjonsson, Johann E.
    Sarkar, Mrinal K.
    Kahlenberg, J. Michelle
    Gerard, Nega
    Teague, Jessica E.
    Kupper, Thomas S.
    Leboeuf, Nicole R.
    Larocca, Cecilia
    Tawa, Marianne
    Pomahac, Bohdan
    Talbot, Simon G.
    Orgill, Dennis P.
    Wolf, Peter
    Clark, Rachael A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (03) : 621 - 632.e1
  • [28] Oral delivery of oligomeric procyanidins in Apple Poly® enhances type I IFN responses in vivo
    Snyder, Deann T.
    Robison, Amanda
    Kemoli, Sharon
    Kimmel, Emily
    Holderness, Jeff
    Jutila, Mark A.
    Hedges, Jodi F.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 95 (05) : 841 - 847
  • [29] Toxoplasma gondii Type I TR and ROP16 Synergistically Downregulate IL-12 to Inhibit Host Reactive Oxygen Species Production
    Geng, Xiaoling
    Li, Ruifang
    Du, Jingying
    Zhang, Manyu
    Jiang, Wei
    Sun, Qing
    Mi, Rongsheng
    Qin, Shuang
    Wang, Quan
    PATHOGENS, 2025, 14 (02):
  • [30] Toxoplasma gondii Type-I ROP18 Targeting Human E3 Ligase TRIM21 for Immune Escape
    Yao, Lijie
    Xu, Liqing
    Zhou, Lijuan
    Wu, Shuizhen
    Zou, Weihao
    Chen, Min
    Chen, Jiating
    Peng, Hongjuan
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9